NP CHRONICLES
Clinical Education for NP Students & New Graduates
CLINICAL
PRACTICE & PUBLIC HEALTH
The Real Cost of Vaccine Hesitancy: What NP Students and New
Grads Are Walking Into
Updated
July 2026
Behind every percentage point and CDC chart is a patient. Right
now, diseases that were once rare or eliminated in the United States are
showing up in exam rooms, EDs, and pediatric ICUs at rates most new grads have
never personally witnessed. This post walks through what the current numbers
actually show, why the “too many shots” narrative doesn't hold up clinically,
and how to talk with hesitant families — grounded in verified data, not
headline math.
The
Numbers Right Now
As of early July 2026, the CDC has confirmed over 2,200 measles
cases across 42 jurisdictions this year — already approaching the full-year
2025 total, which was itself the highest in 25 years. Ninety-three percent of
this year's cases are in people who are unvaccinated or whose vaccination
status is unknown. South Carolina, Utah, Texas, Virginia, and Florida account
for the largest outbreaks.
Pertussis (whooping cough) told a similar story in 2025: roughly
28,000 cases nationally — the highest count since before the pandemic — with at
least 13 confirmed deaths, several of them infants too young to have completed
their own DTaP series.
The 2024–2025 flu season set its own grim record: 266 pediatric
deaths, the most in any non-pandemic season since the CDC began tracking them
in 2004. About 90% of those deaths occurred in children who were not fully
vaccinated against flu.
|
CLINICAL BOTTOM LINE None of these numbers are abstractions. Rising measles,
pertussis, and pediatric flu mortality are direct, measurable consequences of
declining childhood vaccination coverage — which has fallen from about 95% to
roughly 92–93% among U.S. kindergartners in the last several years, below the
~95% threshold needed for reliable herd immunity against measles. |
Debunking
the “Too Many Shots” Narrative
A common argument from vaccine-hesitant parents is that today's
children are overwhelmed by an excessive number of injections. This ignores the
role of combination vaccines, which reduce the number of physical shots even as
protection against more diseases has expanded:
●
DTaP-IPV-HepB-Hib
(e.g., Vaxelis): one injection covering six diseases.
●
DTaP-IPV
(e.g., Kinrix, Quadracel): one injection covering four diseases.
●
MMR: one
injection covering measles, mumps, and rubella.
By bundling antigens, children today generally receive fewer
physical injections per visit than earlier immunization schedules, while
gaining broader protection. The “pincushion” framing conflates the number of
diseases prevented with the number of needle sticks, which are two different
numbers.
The
“Immune Amnesia” Teaching Point
One of the more persuasive clinical facts for hesitant parents
involves what happens after a child survives measles, not just during the
illness. The landmark evidence here comes from Mina et al., published in
Science in 2019: using a technique called VirScan to profile antibody
repertoires in 77 unvaccinated Dutch children before and after natural measles
infection, the researchers found that measles infection eliminated between 11%
and 73% of each child's preexisting antibody repertoire, with a mean reduction
of roughly 20% and more severe cases losing substantially more. A companion
analysis in rhesus macaques found similar losses (40–60%) persisting at least
five months post-infection. Critically, the same effect was not observed in
children who received the MMR vaccine — the live attenuated vaccine strain does
not appear to deplete existing immune memory the way wild-type measles does.
This gives you a concrete, mechanism-based answer to “why does
it matter if my child gets measles and recovers” that goes beyond the acute
illness: measles doesn't just cause a rash and fever, it can measurably erode
protection against unrelated pathogens for a period afterward, with immunity
gradually rebuilding as children are re-exposed to those pathogens.
|
NUANCE Be precise with cost figures if you cite them. Published
cost-per-case estimates for measles outbreaks vary widely by study and
outbreak size — averaging around $43,000 per case in a recent systematic
review, with a range from roughly $7,000 to over $240,000 depending on
outbreak size and which costs are counted (medical, public health response,
or societal). A single-case investigation can carry a fixed startup cost
north of $240,000 regardless of whether the outbreak spreads further. Avoid
citing a single flat number (e.g., “$140,000 per case”) as though it were
universal — the range itself is the more defensible and more clinically
useful fact. |
Illustrative
Clinical Scenarios
|
CASE FROM PRACTICE (COMPOSITE SCENARIOS) The following are composite, illustrative presentations
consistent with documented clinical patterns in the current literature — not
attributed to a single named or verified patient. They reflect the kinds of
presentations NPs across the country are increasingly encountering, and are
useful for patient conversations precisely because they are clinically
realistic, not because they are a specific case report. |
● A neonate
too young for their first DTaP dose (given at 2 months) contracts pertussis
after exposure to an unvaccinated or under-vaccinated household contact,
illustrating why cocooning — vaccinating everyone around a newborn — is the
only protection available in the first two months of life.
● A
school-age child in a community with a measles outbreak and low local
vaccination coverage develops measles after exposure, requiring hospitalization
for hydration and respiratory support — a presentation consistent with
published measles hospitalization rates (roughly 5–11% of confirmed cases this
outbreak cycle).
● A
college-age patient develops meningococcal meningitis, with rapid clinical
deterioration over 24 hours; severe cases can progress to purpura fulminans and
limb-threatening ischemia requiring amputation — a recognized, if uncommon,
outcome documented in the meningococcal disease literature, and part of why
MenACWY vaccination is recommended before college entry.
● An adult
who had wild varicella in childhood (pre-1995, before the varicella vaccine)
develops herpes zoster (shingles) decades later, with a subset progressing to
postherpetic neuralgia — a well-documented long-term consequence of latent VZV
reactivation.
What
This Means for Your Practice
As new NPs, you're stepping into a moment where federal
messaging on vaccines is contested and inconsistent, and patients notice that
inconsistency. A few practical approaches:
●
Lead with
mechanism, not just statistics. Explaining how combination vaccines reduce shot
count, or how immune amnesia works, often lands better than reciting case
counts alone.
●
Validate
the concern, not the conclusion. Parents asking about “too many shots” are
usually expressing love and caution, not hostility. Meet that with empathy
before you correct the premise.
●
Use
precise numbers. Overstating a statistic (even in a good cause) undermines
credibility if a parent looks it up. Cite ranges and sources you can stand
behind.
●
Know the
cocooning strategy for pertussis. Newborns are unprotected until 2 months of
age; Tdap for pregnant patients and close contacts is the primary tool you
have.
Billing
& Coding: Counseling Vaccine-Hesitant Families
Vaccine counseling is real, billable clinical work — and until
recently, coding options for encounters where a vaccine is discussed but not
given were limited. That changed for 2026, when the AMA introduced three new
standalone, time-based CPT codes specifically for this scenario:
●
90482 —
Immunization counseling when the vaccine is not administered on the same date
of service; 3 up to 10 minutes (wRVU 0.24).
●
90483 —
Same scenario, counseling lasting more than 10 up to 20 minutes (wRVU 0.50).
●
90484 —
Same scenario, counseling lasting 20 minutes or longer.
Only one of these three codes may be billed per visit, and they
apply only when the discussed immunization is not given that day — if you
counsel on an HPV vaccine but the patient declines it while accepting a Tdap
booster at the same visit, the Tdap is billed as a standard administration
(90460/90461 for patients through age 18, or 90471–90474 without counseling),
while the HPV conversation may qualify separately for 90482–90484 if the
counseling time is documented.
For vaccines that are administered with documented counseling,
continue using 90460 (first component, patients through 18) plus add-on code
90461 for each additional component, or 99401–99404 for longer preventive
counseling not tied to a specific administration. When billing a counseling
code alongside a same-day E/M visit, append modifier 25 to the E/M code to
indicate a separately identifiable service.
Pair your CPT code with the correct ICD-10 diagnosis. Z71.85
(encounter for immunization safety counseling) fits general vaccine-safety
discussions. For refusal-specific documentation, the Z28.xx family is more
precise: Z28.82 (immunization not administered due to caregiver refusal) is
generally the most accurate code when a parent declines on behalf of a minor,
while Z28.1 (refused for religious reasons) and Z28.89 (other reason) apply to
more specific circumstances. Using Z23 (encounter for immunization) alone,
without a Z28.xx code, implies the vaccine was given — don't use it for a
refusal encounter.
|
NUANCE Coverage and reimbursement for the new 90482–90484 codes are
still uneven across payers as adoption catches up to the 2026 CPT update.
Verify payer-specific policies before relying on these codes for revenue
projections, and document counseling time explicitly in the note (not just
“counseled on vaccines”) since these are time-based codes subject to audit. |
Documenting
Vaccine Refusal in the EHR
Beyond billing, thorough documentation of vaccine refusal is one
of the most important things you can do to protect both your patient and your
practice. A parent's decision to decline is their right — but if a preventable
illness occurs afterward, your note is what shows the conversation happened and
was handled appropriately.
●
Name the
specific vaccine(s) discussed by name, not just “vaccines” generally — e.g.,
“MMR, DTaP, and Hib discussed” rather than “immunizations discussed.”
●
Document
that risks of the disease and risks/benefits of the vaccine were explained, and
that the caregiver's questions were addressed.
●
Record the
specific reason given for refusal, in the caregiver's own words where possible,
rather than a generic “declined.”
●
Note that
you offered to answer further questions and invited the family to revisit the
decision at a future visit — refusal should be treated as an ongoing
conversation, not a one-time closed door.
●
Use the
correct Z28.xx code (see above) so the chart itself reflects informed refusal
rather than a missed or overlooked immunization.
●
Consider
using a signed informed-refusal form for the medical record. The American
Academy of Pediatrics provides a Refusal to Vaccinate template that many
practices adapt; AAP is explicit that the form itself is not a substitute for
legal advice and should be reviewed with your practice's attorney or
risk-management team.
●
Avoid
discharging a family from the practice solely over vaccine refusal unless that
is your practice's established, uniformly applied policy — inconsistent
application can itself create liability, and continuity of care preserves your
ability to revisit the conversation over time.
|
CLINICAL BOTTOM LINE Good refusal documentation does three things at once: it
protects the practice legally, it creates a record you can revisit at the
next visit without starting from zero, and it keeps the door open for a
family to change their mind. Treat the note as part of the ongoing
relationship, not a liability checkbox. |
Board
Prep: Quick Review
|
BOARD PREP Q: Why is Tdap recommended during pregnancy rather than
relying solely on the infant's own vaccination schedule? A: Infants cannot
receive their first DTaP dose until 2 months of age; maternal Tdap during the
third trimester transfers protective antibodies (cocooning) to protect the
newborn during this vulnerable window. Q: What is “immune amnesia” in the context of measles
infection? A: Wild measles infection can eliminate a substantial portion of a
child's pre-existing antibody repertoire, leaving them more susceptible to
other infections for a period after recovery — an effect not caused by the
MMR vaccine. Q: Why do combination vaccines (e.g., DTaP-IPV-HepB-Hib)
matter clinically? A: They reduce the total number of injections a child
receives while maintaining or improving protection against multiple diseases,
addressing “too many shots” concerns with a factual counterpoint. Q: A parent declines the HPV vaccine after a 12-minute
counseling discussion, and no vaccine is given that day. What CPT code
applies? A: 90483 (immunization counseling when the vaccine is not
administered, 10–20 minutes). Q: Which ICD-10 code most precisely documents a caregiver's
refusal of a vaccine on behalf of a minor? A: Z28.82 (immunization not
administered due to caregiver refusal) — more precise than Z23, which implies
the vaccine was given. |
The
Bottom Line
The current resurgence of measles, pertussis, and severe
pediatric flu isn't a theoretical risk — it's measurable, current, and
disproportionately affecting unvaccinated and under-vaccinated children. As an
NP, your clinical explanations of mechanism — why cocooning matters, how
combination vaccines actually work, what immune amnesia does — are often more
persuasive to hesitant families than statistics alone. Precision matters here:
citing verified numbers, and being upfront about ranges and uncertainty where
they exist, protects your credibility and your patients.
References
1. CDC.
“Measles Cases and Outbreaks.” Measles (Rubeola). Updated July 2026.
cdc.gov/measles/data-research.
2. American
Academy of Pediatrics, Red Book Online. “Outbreaks: Measles.” Updated 2026.
publications.aap.org/redbook.
3. Scientific
American. “Whooping Cough Deaths Rise in U.S. as Surge in Infections
Continues.” December 2025.
4. New York
Academy of Sciences. “Whooping Cough Is Surging in the U.S.: What You Need to
Know.” November 2025.
5. CDC. “Flu
and Children.” Influenza (Flu). Data as of May 2026.
cdc.gov/flu/highrisk/children.html.
6. American
Hospital Association News. “Pediatric flu deaths reach 266 for 2024–2025
season.” July 2025.
7.
Quantifying the Cost of Measles Outbreaks in the U.S. and How Costs Scale with
Outbreak Size. medRxiv preprint, October 2025.
8. Johns
Hopkins Bloomberg School of Public Health, International Vaccine Access Center.
“Estimating the Financial Costs of Measles Outbreaks.” November 2025.
9. ASTHO.
“The Cost of Measles and Public Health Implications.” March 2026.
10. CDC.
“Pertussis Surveillance and Trends.” Whooping Cough. Updated 2026.
cdc.gov/pertussis/php/surveillance.
11. NACCHO.
“2025–2026 Measles Outbreaks: Where Are We Now?” January 2026.
12. Mina MJ,
Kula T, Leng Y, et al. “Measles virus infection diminishes preexisting
antibodies that offer protection from other pathogens.” Science.
2019;366(6465):599–606.
13. American
Academy of Family Physicians. “Measles Infection Weakens Global Immune
Defenses, Say Studies.” AAFP News, November 2019.
14. AAPC.
“Use These New Immunization Counseling Codes in Your Practice.” Pediatric
Coding Alert, January 2026.
15. PCC. “New
for 2026: Coding for Immunization Counseling When Vaccines Aren't Given.”
January 2026.
16. American
Academy of Pediatrics. “Refusal to Vaccinate.” Implementing Immunization
Administration in Your Practice. aap.org.
